Aligos Therapeutics, Inc. (ALGS)

Last Closing Price: 1.30 (2026-11-18)

End Cash (Quarterly)

End Cash: The amount of cash held by the company for the given period.

Aligos Therapeutics, Inc. (ALGS) had End Cash of $31.74M for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
$2.87M
$-21.86M
--
$2.87M
$24.76M
$-21.89M
$0.36M
$-21.53M
$-21.53M
$-21.86M
$-21.86M
$-21.86M
$-21.86M
$-21.89M
$-21.64M
10.46M
10.46M
$-2.09
$-2.09
Balance Sheet Financials
$34.68M
$1.21M
$12.51M
$47.19M
$19.60M
--
$16.28M
$35.88M
$11.31M
$11.31M
$11.31M
6.25M
Cash Flow Statement Financials
$-46.63M
$59.80M
$0.15M
$18.41M
End Cash
$31.74M
$13.33M
$3.96M
--
--
Fundamental Metrics & Ratios
1.77
--
--
--
0.01
100.00%
-762.98%
-762.98%
--
-750.58%
-761.94%
$-46.82M
--
--
--
0.06
--
--
--
-193.35%
-193.35%
-46.32%
-193.35%
$1.81
$-4.48
$-4.46